国际医药卫生导报
國際醫藥衛生導報
국제의약위생도보
INTERNATIONAL MEDICINE & HEALTH GUIDANCE NEWS
2010年
11期
1309-1312
,共4页
骆荣江%李小敏%朱文珲%刘韶瑞%朱慧萍%曾平
駱榮江%李小敏%硃文琿%劉韶瑞%硃慧萍%曾平
락영강%리소민%주문혼%류소서%주혜평%증평
白内障%独眼%手术%风险%规避
白內障%獨眼%手術%風險%規避
백내장%독안%수술%풍험%규피
Cataract%Unique eye%Surgery%Risk%Avoidanc
目的 探讨独眼白内障患者施行白内障手术联合人工晶状体植入的效果及其风险规避措施.方法 对58例(58眼)"独眼"白内障患者,严格选择手术适应症;制定周密细致的术前准备和个性化的手术方案;对Ⅳ级以上白内障核患者28例采取白内障囊外摘出术(A组);对Ⅲ级以下白内障核患者30例则采取透明角膜切口超声乳化术(B组).术后随访6~12个月,观察疗效.结果 术后两组患者视力均有不同程度提高,术后3个月视力:A组患者视力在0.2~0.5者为16眼(57.14%);0.6以上者12眼(42.86%);B组患者视力在0.2~0.5者为18眼(60.00%);0.6以上者12眼(40.00%).两组患者的视力差异无显著性(P>0.05).两组患者在手术并发症方面,诸如术中后囊膜破裂并玻璃体脱出、术后角膜水肿、角膜内皮失代偿等方面的差异也无显著性(P<0.05).结论 只要本着极端认真负责细致的态度,独眼白内障手术是安全有效的;且采取何种手术方式主要取决于设备条件以及术者对该术掌握的熟练程度.
目的 探討獨眼白內障患者施行白內障手術聯閤人工晶狀體植入的效果及其風險規避措施.方法 對58例(58眼)"獨眼"白內障患者,嚴格選擇手術適應癥;製定週密細緻的術前準備和箇性化的手術方案;對Ⅳ級以上白內障覈患者28例採取白內障囊外摘齣術(A組);對Ⅲ級以下白內障覈患者30例則採取透明角膜切口超聲乳化術(B組).術後隨訪6~12箇月,觀察療效.結果 術後兩組患者視力均有不同程度提高,術後3箇月視力:A組患者視力在0.2~0.5者為16眼(57.14%);0.6以上者12眼(42.86%);B組患者視力在0.2~0.5者為18眼(60.00%);0.6以上者12眼(40.00%).兩組患者的視力差異無顯著性(P>0.05).兩組患者在手術併髮癥方麵,諸如術中後囊膜破裂併玻璃體脫齣、術後角膜水腫、角膜內皮失代償等方麵的差異也無顯著性(P<0.05).結論 隻要本著極耑認真負責細緻的態度,獨眼白內障手術是安全有效的;且採取何種手術方式主要取決于設備條件以及術者對該術掌握的熟練程度.
목적 탐토독안백내장환자시행백내장수술연합인공정상체식입적효과급기풍험규피조시.방법 대58례(58안)"독안"백내장환자,엄격선택수술괄응증;제정주밀세치적술전준비화개성화적수술방안;대Ⅳ급이상백내장핵환자28례채취백내장낭외적출술(A조);대Ⅲ급이하백내장핵환자30례칙채취투명각막절구초성유화술(B조).술후수방6~12개월,관찰료효.결과 술후량조환자시력균유불동정도제고,술후3개월시력:A조환자시력재0.2~0.5자위16안(57.14%);0.6이상자12안(42.86%);B조환자시력재0.2~0.5자위18안(60.00%);0.6이상자12안(40.00%).량조환자적시력차이무현저성(P>0.05).량조환자재수술병발증방면,제여술중후낭막파렬병파리체탈출、술후각막수종、각막내피실대상등방면적차이야무현저성(P<0.05).결론 지요본착겁단인진부책세치적태도,독안백내장수술시안전유효적;차채취하충수술방식주요취결우설비조건이급술자대해술장악적숙련정도.
Objective To investigate the efficacy and risk avoidance of unique eye cataract surgery. Methods Fifty-eight patients with unique eye cataract were divided into two groups according to different surgical procedures. 28 eyes with nuclear grade > Ⅳ received extracapsular cataract extraction and 30 eyes with nuclear grade < Ⅲ received phacoemulsification. All the patients were followed up for 6 to 12 months. Regulate Visual acuity (VA) was raised to different degrees in all the patients 3 months after the procedures. 12 eyes (42.86%) achieved corrected VA of 2s0.6 and 16 (57.14%) achieved 0.2-0.5 in group A; while 18 eyes (60%) achieved 0.2-0.5 and 12 eyes (40%) achieved ≥0.6 in group B. VA did not differ significantly between the two groups (P>0.05). There were no significant differences between the two groups in complications concluding intrasurgical posterior capsular rupture with prolapse of vitreous body, and postsurgical cornea edema (P>0.05). Conclusions Cataract surgery is safe and effective in the treatment of unique eye cataract. Selection of a procedure mainly depends on the available surgical equipment and how skillful an ophthalmologist is in this procedure.